BaseClear will become the first Ultima Certified Service Provider in Europe and offer sequencing services on the UG200 Platform that unlock a new level of scale and economics for a wide range of data-intensive applications Builds upon BaseClear’s selection as the commercial service provider for Basecamp Research’s AI-scale Trillion-Gene Atlas to be run on Ultima’s […]

CAMARILLO, Calif. — PBS Biotech, a leader in advanced cell therapy manufacturing technologies, today announced its membership in Organoid COMMONS. As a member of this industry-first consortium, PBS Biotech will collaborate with biopharma pioneers to establish the biomanufacturing standards and scalable frameworks required to transition organoid technologies from early-stage drug discovery to commercial-scale application. Organoid […]

Stellar Scientific and Exymes team up to deliver innovative, highly efficient DNA extraction solutions to research facilities across the United States. Stellar Scientific – a leading national supplier of research products, tools, and laboratory equipment, has a strategic distribution partnership with Exymes, an innovative developer of molecular biology reagents. This collaboration brings next-generation DNA and […]

The German innovation project targets the reproducibility gap that keeps ion-mobility and imaging mass spectrometry data from being compared reliably across instruments and laboratories. Polymer Factory has joined LIMMIC, a German innovation project developing a universal standard for calibrating multidimensional mass spectrometry data. Polymer Factory will develop the polymer-based reference standards at its core: the […]

New strategic collaboration introduces a scalable alternative to traditional LIMS / LIS configuration models—empowering laboratories to accelerate time-to-value while maintaining operational control and regulatory confidence. TUCSON, Ariz. — Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform. Together, the […]

Lucid Genomics provides in-kind access to its genomic analysis platform for laboratories participating in global undiagnosed disease genomics program. By providing our platform in-kind, we hope to help reduce barriers to genomic diagnostics and support Genetic Alliance’s efforts to expand equitable access for patients with rare diseases.” — Uira Souto Melo, Co-Founder and CEO at […]

Yokohama, Japan / Suzhou, China – REPROCELL Inc., a global provider of clinical-grade iPSC technologies and regenerative medicine solutions, today announced a strategic collaboration with WEIPU Biotechnology Co., Ltd., a biotechnology company based in Suzhou, China, to support cell therapy developers in China with access to high-quality clinical starting materials and complementary biological testing services. […]

Pythia Biosciences and Lexogen recently announced a strategic partnership to empower researchers with deeper biological insights by combining Lexogen’s expertise in RNA sequencing and library preparation with Pythia’s multi-omics data curation and analytics capabilities. Through this collaboration, Pythia will offer Lexogen’s wet-lab capabilities via direct sales and as a core component of its newly launched expanded data ecosystem […]

immunoMUSE® enables flexible, high-sensitivity multiplex immunofluorescence with user-defined antibodies. Schlieren, Switzerland – arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services. Through this partnership, Europa Biosite will distribute arcoris bio’s newly launched immunoMUSE® kits in […]

Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced that it has entered into a technology license partnership […]